prolinedithiocarbamate has been researched along with Bowel Diseases, Inflammatory in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andoh, A; Araki, Y; Bamba, S; Bamba, T; Fujino, S; Fujiyama, Y; Hata, K; Okuno, T; Shimada, M | 1 |
1 other study(ies) available for prolinedithiocarbamate and Bowel Diseases, Inflammatory
Article | Year |
---|---|
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts.
Topics: Antineoplastic Agents; Cells, Cultured; Chemokine CCL2; Colon; Enzyme Inhibitors; Fibroblasts; Gene Expression; Humans; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-17; Interleukin-6; Interleukin-8; Mitogen-Activated Protein Kinases; NF-kappa B; Proline; Protein Synthesis Inhibitors; RNA, Messenger; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Tumor Necrosis Factor-alpha | 2002 |